{"id":131511,"date":"2026-06-25T17:09:52","date_gmt":"2026-06-25T11:39:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=131511"},"modified":"2026-10-07T11:32:05","modified_gmt":"2026-10-07T06:02:05","slug":"sai-life-sciences-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sai-life-sciences-share-price-target-2026\/","title":{"rendered":"Sai Life Sciences Share Price Target 2026: Stock Analysis, Share Price Today, Bull Case and Bear Case After Q1 FY27"},"content":{"rendered":"
\n

META TITLE:<\/strong> Sai Life Sciences Share Price Target 2026 and Share Price Today<\/p>\n

META DESCRIPTION:<\/strong> Sai Life Sciences share price target 2026: Rs 1,392 to Rs 1,680 vs Rs 1,558.10. Share price today, stock analysis, buy or sell, bull and bear case, 12-month target.<\/p>\n

SLUG:<\/strong> sai-life-sciences-share-price-target-2026<\/p>\n

PRIMARY KEYWORD:<\/strong> Sai Life Sciences share price target<\/p>\n

SECONDARY KEYWORDS:<\/strong> Sai Life Sciences share price today, Sai Life Sciences stock analysis, Sai Life Sciences buy or sell, Sai Life Sciences share price forecast, Sai Life Sciences stock price target 2027, Sai Life Sciences price target, Sai Life Sciences buy or sell<\/p>\n

LSI KEYWORDS:<\/strong> analyst consensus, bull case, bear case, 12-month target, PE multiple, EPS estimate, sector tailwinds, institutional holding, resistance level, FY27 outlook<\/p>\n<\/div>\n

Sai Life Sciences Rs 1,558.10 (6 Oct 2026 close). 52-week range Rs 783.85 to Rs 1,697.00. Q1 FY27 revenue Rs 554 cr, up 12%; profit Rs 73 cr, up 22%.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The Sai Life Sciences share price target for 2026 is Rs 1,392 to Rs 1,680, which is between 11 percent below and 8 percent above the last close of Rs 1,558.10, with bull and bear cases of Rs 2,040 to Rs 2,280 and Rs 765 to Rs 935. Sai Life Sciences reported Q1 FY27 revenue up 12 percent to Rs 554 crore, EBITDA up 18 percent to Rs 148 crore at a 27 percent margin and profit up 22 percent to Rs 73 crore, with CRO revenue up 24 to 26 percent. CDMO revenue grew only 6 percent, FY27 capex is guided at Rs 1,100 to Rs 1,300 crore, and the stock trades at 91 times earnings after rising 81 percent in a year. No brokerage price target was available on the sources we track as of 6 October 2026, so every range below is a Univest research scenario.<\/p>\n<\/p><\/div>\n

The Sai Life Sciences<\/a> share price target for 2026 is Rs 1,392 to Rs 1,680 in the Univest base case, with the stock at Rs 1,558.10 at the 6 October 2026 close. That is 8.2 percent below its 52-week high of Rs 1,697.00 and 98.8 percent above its 52-week low of Rs 783.85, and the stock moved up 80.9 percent over the past year. Sai Life Sciences is a Hyderabad-based CRDMO that does contract research, development and manufacturing for global pharma and biotech firms. Debt to equity is 0.12 and the company pays no dividend.<\/p>\n

Three things changed since the last update: Q1 FY27 results on 6 August showed profit up 22 percent, the stock fell 2 to 4 percent after them, and it then rose 6.7 percent in the week of 31 August to a high of Rs 1,697 in the week of 7 September. This Sai Life Sciences stock analysis covers the Sai Life Sciences share price today, the Sai Life Sciences share price target for 2026, 2027 and 2030, the Q1 FY27 numbers, catalysts and risks, key price levels and a Sai Life Sciences buy or sell view.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n